Thalidomide for graft-versus-host disease after bone marrow transplantation.

Lancet (London, England) ·Vol. 1 ·No. 8581 ·1988-02-13 ·Pages 359

Saurat JH, Camenzind M, Helg C, Chapuis B

Abstract

暂无摘要

MeSH Terms

Acute Disease Adult Bone Marrow Transplantation Drug Administration Schedule Graft vs Host Disease/drug therapy Humans Male Thalidomide/administration & dosage,therapeutic use

Chemicals

Thalidomide

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Saurat J H

Camenzind M

Helg C

Chapuis B

Article Info

Journal

Lancet (London, England)

Abbr.

Lancet

ISSN

0140-6736

DOI

10.1016/s0140-6736(88)91151-8

Published

1988-02-13

Pages

359

Language

English

Region

England

NLM ID

2985213R

Subset

External Links

PubMed source DOI: 10.1016/s0140-6736(88)91151-8 View journal details

Analysis Services

Thalidomide for graft-versus-host disease after bone marrow transplantation.

Contact

WeChat Official Account